Dongin (Donoven) Kim, Ph.D.

---

Publications & Presentations

1. Kang C, Ren X, Lee D, Ramesh R, Nimmo S, Yang-Hartwich Y, Kim D. Harnessing small extracellular vesicles for pro-oxidant delivery: novel approach for drug-sensitive and resistant cancer therapy. Journal of Controlled Release/ELSEVIER. 2024; 365 : 286-300

2. Rana S, Kang C, Allred J, Medina-Duran J H, Canova A, Sherry D, Woller D A, Kim D, Song H. Differential responses to double-stranded RNA injection and feeding in Mormon cricket (Orthoptera: Tettigoniidae) . Journal of Insect Science/Oxford Academic. 2023; 23

3. Ren X, Kang C, Garcia-Contreras L, Kim D. Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications. International Journal of Molecular Sciences/MDPI. 2023; 24 : 8166

4. Kang C, Ren X, Garcia-Contreras L, Kim D. Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications. International Journal of Molecular Sciences . 2023; 24 : 8166

5. Kim D. A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice. Pharmaceutics/MDPI. 2022; 14 : 84

Grants

6. Role of Renal Lymphatics in Blood Pressure Regulation. NIH. Start Date: 2018. End Date: 2023.

7. Cancer exosome mediated antibody production for active tumor targeting treatment. Non-federal. Start Date: 2022. End Date: 2023.

8. Engineering Exosome for Ovarian Cancer Targeting Therapy. NIH. Start Date: 2021. End Date: 2023.

9. Exosome based intraocular therapy combined with active targeting of ocular neovascularization. NIH. Start Date: 2022. End Date: 2022.

10. Translational Studies on Extracellular Vesicles in Ovarian Cancer. Non-federal. Start Date: 2022. End Date: 2022.

Awards and Honors

no results

Education

1. Degree: Ph D. University of Utah. Date: 2009.


2. Degree: MS. University of Florida. Date: 2002.


3. Degree: BS. Ajou University. Date: 1999.

Administrative Assignments

no results